Search results
Results from the Go Local Guru Content Network
Website. sanofigenzyme.com. Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing ...
Henri A. Termeer (February 28, 1946 – May 12, 2017) [5] was a Dutch biotechnology executive and entrepreneur who is considered a pioneer [6] in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. [7] Termeer created a business model [6] adopted by many others in the biotech industry by garnering steep prices ...
Alemtuzumab. Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. [8] In chronic lymphocytic leukemia, it has been used as both a first line and second line treatment. [8] It is given by injection into a vein.
Genzyme (GENZ) shares are declining over 5% in mid-day trading after the company said Wednesday the U.S. Food and Drug Administration will take enforcement action to ensure that products ...
Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the recipients of ...
Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE ...
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics [3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. [4] In 2016, Forbes included the company on its "100 ...
Genzyme Honors Innovation in Gaucher Disease Research through Its 2012 Gaucher Generation Program Awards CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY ...